Biglycan acts as a DAMP, and here we provided evidence demonstrating that stromal biglycan promotes TNF-α expression in tumor cells through binding to TLR2 or TLR4, and subsequent activation of NF-κB and ERK signaling pathways. This evidence concerns the gene TNF and neoplasm.